These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15509424)

  • 21. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
    Burkot TR; Taleo G; Toeaso V; Ichimori K
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.
    Ramaiah KD; Vanamail P; Das PK
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):250-5. PubMed ID: 16890256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of methods for estimating drug coverage for filariasis elimination, Leogane Commune, Haiti.
    Mathieu E; Deming M; Lammie PJ; McLaughlin SI; Beach MJ; Deodat DJ; Addiss DG
    Trans R Soc Trop Med Hyg; 2003; 97(5):501-5. PubMed ID: 15307410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
    Chanteau S; Roux JF
    Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The roles of stakeholder experience and organizational learning in declining mass drug administration coverage for lymphatic filariasis in Port-au-Prince, Haiti: A case study.
    Wodnik BK; Louis DH; Joseph M; Wilkers LT; Landskroener SD; Desir L; Lemoine JF; Lavery JV
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008318. PubMed ID: 32469860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knowledge on lymphatic filariasis and the response to July 2002 mass treatment campaign in two communities in the Galle district.
    Yahathugoda TC; Wickramasinghe D; Liyanage TS; Weerasooriya MV; Mudalige MP; Waidyaratna EI; Samarawickrema WA
    Ceylon Med J; 2003 Sep; 48(3):74-7. PubMed ID: 14735801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India.
    Kerketta AS; Babu BV
    Asia Pac J Public Health; 2009 Jan; 21(1):112-7. PubMed ID: 19124342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA.
    Kisoka WJ; Tersbøl BP; Meyrowitsch DW; Simonsen PE; Mushi DL
    J Biosoc Sci; 2016 Jan; 48(1):94-112. PubMed ID: 25790081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A survey of knowledge, attitudes, and perceptions (KAPs) of lymphatic filariasis, elephantiasis, and hydrocele among residents in an endemic area in Haiti.
    Eberhard ML; Walker EM; Addiss DG; Lammie PJ
    Am J Trop Med Hyg; 1996 Mar; 54(3):299-303. PubMed ID: 8600770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors determining non-compliance to mass drug administration for lymphatic filariasis elimination in endemic districts of Nepal.
    Adhikari RK; Sherchand JB; Mishra SR; Ranabhat K; Devkota P; Mishra D; Ghimire YC; Gelal K; Mishra R; Paudel R; Wagle RR
    J Nepal Health Res Counc; 2014; 12(27):124-9. PubMed ID: 25726571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. School-based health education campaign--a potential tool for social mobilization to promote the use of DEC-fortified salt towards elimination of lymphatic filariasis.
    Nandha B; Krishnamoorthy K
    Health Educ Res; 2007 Aug; 22(4):539-46. PubMed ID: 17035351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
    Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
    Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
    Bockarie MJ; Deb RM
    Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
    Ramzy RM; El Setouhy M; Helmy H; Ahmed ES; Abd Elaziz KM; Farid HA; Shannon WD; Weil GJ
    Lancet; 2006 Mar; 367(9515):992-9. PubMed ID: 16564361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka.
    Gunawardena S; Ismail M; Bradley M; Karunaweera N
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):445-53. PubMed ID: 17125809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing knowledge about lymphatic filariasis and the implementation of mass drug administration amongst drug deliverers in three districts/cities of Indonesia.
    Titaley CR; Damayanti R; Soeharno N; Mu'asyaroh A; Bradley M; Lynam T; Krentel A
    Parasit Vectors; 2018 May; 11(1):315. PubMed ID: 29801511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment.
    Ahorlu CSK; Koka E; Adu-Amankwah S; Otchere J; de Souza DK
    BMC Public Health; 2018 Feb; 18(1):238. PubMed ID: 29433461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of education campaign on community-based vector control in hastening the process of elimination of lymphatic filariasis in Tamil Nadu, South India.
    Nandha B; Krishnamoorthy K
    Health Educ Res; 2012 Aug; 27(4):585-94. PubMed ID: 21724963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.
    De Rochars MB; Direny AN; Roberts JM; Addiss DG; Radday J; Beach MJ; Streit TG; Dardith D; Lafontant JG; Lammie PJ
    Am J Trop Med Hyg; 2004 Oct; 71(4):466-70. PubMed ID: 15516644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in American Samoa.
    Mladonicky JM; King JD; Liang JL; Chambers E; Pa'au M; Schmaedick MA; Burkot TR; Bradley M; Lammie PJ
    Am J Trop Med Hyg; 2009 May; 80(5):769-73. PubMed ID: 19407122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.